Abbott received FDA authorization for the Libre Duo 10 Day system, marking it as the world's first dual glucose-ketone sensing technology.
Published
Signal category
Products & Services
Quote
“FDA authorization of Libre Duo 10 Day system marks an exciting step forward as the world's first dual glucose-ketone sensing technology*”
— John White|Abbott team
Company
- Industry
- Hospitals and Health Care
- Location
- Abbott Park, US
- Company size
- 152,598 employees
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on X @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce. Terms of Use: https://www.abbott.com/social-media-terms-of-use.html Privacy Policy: https://abbo.tt/privacy